Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L B Sheiner

Showing results (41-50 of 142) with videos related to

Pageof 15
Sort By:
Clinical Pharmacology and Therapeutics|January 1, 1995
Intention-to-treat analysis and the goals of clinical trialsL B Sheiner, D B Rubin
Journal of Pharmacokinetics and Biopharmaceutics|October 1, 1981
Evaluation of methods for estimating population pharmacokinetic parameters. II. Biexponential model and experimental pharmacokinetic dataL B Sheiner, S L Beal
Pharmacology & Therapeutics|January 1, 1982
Kinetics of pharmacologic responseN H Holford, L B Sheiner
Journal of Pharmacokinetics and Biopharmaceutics|June 1, 1983
Evaluation of methods for estimating population pharmacokinetic parameters. III. Monoexponential model: routine clinical pharmacokinetic dataL B Sheiner, S L Beal
Clinical Pharmacokinetics|November 1, 1984
Population pharmacokinetics of procainamide from routine clinical dataT H Grasela, L B Sheiner
Critical Reviews in Bioengineering|January 1, 1981
Pharmacokinetic and pharmacodynamic modeling in vivoN H Holford, L B Sheiner
Clinical Pharmacokinetics|December 1, 1993
Time and theophylline concentration help explain the recovery of peak flow following acute airways obstruction. Population analysis of a randomised concentration controlled trialN Holford, Y Hashimoto, L B Sheiner
Journal of Pharmacokinetics and Pharmacodynamics|October 27, 2001
The need for mixed-effects modeling with population dichotomous dataI Yano, S L Beal, L B Sheiner
Computers and Biomedical Research, an International Journal|October 1, 1972
Modelling of individual pharmacokinetics for computer-aided drug dosageL B Sheiner, B Rosenberg, K L Melmon
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1989
Pharmacodynamic modeling of verapamil effects under steady-state and nonsteady-state conditionsJ B Schwartz, D Verotta, L B Sheiner
Pageof 15

Showing results (41-50 of 142) with videos related to

Sort By:
Pageof 15
Clinical Pharmacology and Therapeutics|January 1, 1995
Intention-to-treat analysis and the goals of clinical trialsL B Sheiner, D B Rubin
Journal of Pharmacokinetics and Biopharmaceutics|October 1, 1981
Evaluation of methods for estimating population pharmacokinetic parameters. II. Biexponential model and experimental pharmacokinetic dataL B Sheiner, S L Beal
Pharmacology & Therapeutics|January 1, 1982
Kinetics of pharmacologic responseN H Holford, L B Sheiner
Journal of Pharmacokinetics and Biopharmaceutics|June 1, 1983
Evaluation of methods for estimating population pharmacokinetic parameters. III. Monoexponential model: routine clinical pharmacokinetic dataL B Sheiner, S L Beal
Clinical Pharmacokinetics|November 1, 1984
Population pharmacokinetics of procainamide from routine clinical dataT H Grasela, L B Sheiner
Critical Reviews in Bioengineering|January 1, 1981
Pharmacokinetic and pharmacodynamic modeling in vivoN H Holford, L B Sheiner
Clinical Pharmacokinetics|December 1, 1993
Time and theophylline concentration help explain the recovery of peak flow following acute airways obstruction. Population analysis of a randomised concentration controlled trialN Holford, Y Hashimoto, L B Sheiner
Journal of Pharmacokinetics and Pharmacodynamics|October 27, 2001
The need for mixed-effects modeling with population dichotomous dataI Yano, S L Beal, L B Sheiner
Computers and Biomedical Research, an International Journal|October 1, 1972
Modelling of individual pharmacokinetics for computer-aided drug dosageL B Sheiner, B Rosenberg, K L Melmon
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1989
Pharmacodynamic modeling of verapamil effects under steady-state and nonsteady-state conditionsJ B Schwartz, D Verotta, L B Sheiner
Pageof 15